Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Current Assets: 2010-2024

Historic Current Assets for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $113.7 million.

  • Anika Therapeutics' Current Assets fell 25.36% to $101.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.6 million, marking a year-over-year decrease of 25.36%. This contributed to the annual value of $113.7 million for FY2024, which is 30.41% down from last year.
  • Anika Therapeutics' Current Assets amounted to $113.7 million in FY2024, which was down 30.41% from $163.3 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Current Assets registered a high of $177.4 million during FY2020, and its lowest value of $113.7 million during FY2024.
  • Over the past 3 years, Anika Therapeutics' median Current Assets value was $163.3 million (recorded in 2023), while the average stood at $148.8 million.
  • Per our database at Business Quant, Anika Therapeutics' Current Assets rose by 0.60% in 2022 and then crashed by 30.41% in 2024.
  • Anika Therapeutics' Current Assets (Yearly) stood at $177.4 million in 2020, then declined by 4.99% to $168.5 million in 2021, then rose by 0.60% to $169.5 million in 2022, then fell by 3.68% to $163.3 million in 2023, then crashed by 30.41% to $113.7 million in 2024.